Behavioral effects of modafinil and nicotine, alone and in combination, in tobacco-deprived young adult smokers

Journal of Clinical Psychopharmacology

Volumn 34, Issue 2, 2014, Pages 278-281

  Martin, Catherine Anne ^a   Lile, Joshua ^a   Guenthner, Greg ^a   Anestis, Joye C ^a   Batten, Seth R ^a   Kelly, Thomas H ^a  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MODAFINIL; NICOTINE; NICOTINE LOZENGE; PLACEBO;

BEHAVIORAL RESEARCH; DRUG DOSE INCREASE; DRUG EFFECT; DRUG TOLERABILITY; DRUG USE; HUMAN; LETTER; NICOTINE REPLACEMENT THERAPY; PATIENT ASSESSMENT; PRIORITY JOURNAL; SELF REPORT; SMOKING; SMOKING CESSATION; WEIGHT REDUCTION; WITHDRAWAL SYNDROME;

ADOLESCENT; BENZHYDRYL COMPOUNDS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; NICOTINE; NICOTINIC AGONISTS; SMOKING; SMOKING CESSATION; SUBSTANCE WITHDRAWAL SYNDROME; WAKEFULNESS-PROMOTING AGENTS; YOUNG ADULT;

EID: 84896387918     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/JCP.0000000000000080     Document Type: Letter

References (15)

1. Sofuoglu M, Waters AJ, Mooney M. Modafinil and nicotine interactions in abstinent smokers. Hum Psychopharmacol. 2008;23: 21-30.
2. Schnoll RA, Wileyto EP, Pinto A, et al. A placebo-controlled trial of modafinil for nicotine dependence. Drug Alcohol Depend. 2008;98: 86-93.
3. Burton SL, Gitchell JG, Shiffman S. Use of FDA-approved pharmacologic treatments for tobacco dependence: United States, 1984-1998. MMWR Morb Mortal Wkly Rep. 2000;49: 665-668.
4. Wee CC, Rigotti NA, Davis RB, et al. Relationship between smoking and weight control efforts among adults in the United States. Arch Intern Med. 2001;161: 546-550.
5. Henningfield JE, Stitzer ML, Griffiths RR. Expired air carbon monoxide accumulation and elimination as a function of number of cigarettes smoked. Addict Behav. 1980;5: 265-272.
6. Shiffman SM, Jarvik ME. Smoking withdrawal symptoms in two weeks of abstinence. Psychopharmacology (Berl). 1976;50: 35-39.
7. Cox LS, Tiffany ST, Christen AG. Evaluation of the brief questionnaire of smoking urges (QSU-brief) in laboratory and clinical settings. Nicotine Tob Res. 2001;3: 7-16.
8. Conners CK. The Conners' Continuous Performance Test. Toronto, Canada: Multi-Health Systems, Inc, 1994.
9. Makris AP, Rush CR, Frederich RC, et al. Wake-promoting agents with different mechanisms of action: comparison of effects of modafinil and amphetamine on food intake and cardiovascular activity. Appetite. 2004;42: 185-195.
10. Perkins KA, Sexton JE, DiMarco A, et al. Acute effects of tobacco smoking on hunger and eating in male and female smokers. Appetite. 1994;22: 149-158.
11. Pomerleau CS, Kurth CL. Willingness of female smokers to tolerate postcessation weight gain. J Subst Abuse. 1996;8: 371-378.
12. Westmaas JL, Langsam K. Unaided smoking cessation and predictors of failure to quit in a community sample: effects of gender. Addict Behav. 2005;30: 1405-1424.
13. Adan A, Prat G, Sánchez-Turet M. Effects of nicotine dependence on diurnal variations of subjective activation and mood. Addiction. 2004;99: 1599-1607.
14. Wetter DW, Fiore MC, Baker TB, et al. Tobacco withdrawal and nicotine replacement influence objective measures of sleep. J Consult Clin Psychol. 1995;63: 658-667.
15. Goeders NE, Guerin GF. Effects of the combination of metyrapone and oxazepam on cocaine and food self-administration in rats. Pharmacol Biochem Behav. 2008;91(1): 181-189.